Drug intelligence / Profile preview

acetaminophen + cysteine + methionine

Development stage
Preclinical
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous
01

Overview

This is a combination drug consisting of acetaminophen (also known as paracetamol), L-cysteine, and L-methionine. Acetaminophen is a widely used analgesic and antipyretic agent. Both L-cysteine and L-methionine are amino acids involved in the synthesis of glutathione, a critical antioxidant that protects cells from oxidative damage. The rationale for combining these agents is to reduce the risk of liver toxicity associated with acetaminophen use or overdose by supporting glutathione synthesis through direct substrate provision (cysteine) and precursor support (methionine). Methionine has been co-formulated with paracetamol in some products as an antidote strategy for overdose, while cysteine supplementation may further enhance hepatic protection by directly contributing to glutathione biosynthesis[1][3][5]. This combination aims to mitigate hepatotoxicity by ensuring adequate substrates for rapid glutathione replenishment during periods of increased demand.

Other names
acetaminophen + cysteine + methionineparacetamol + cysteine + methionine
02

Targets

COX-3 (Prostaglandin-endoperoxide synthase 1 splice variant)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on acetaminophen + cysteine + methionine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetaminophen + cysteine + methionine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call